Will Gaines

Will Gaines is currently serving as a Long/Short Equity Analyst specializing in Healthcare at J. Goldman & Co., L.P., since June 2023. Previously, Will was an Analyst at Roivant Sciences from May 2021 to June 2023, where responsibilities included managing the acquisition of a regulatory compliance SaaS company, conducting evaluations for potential in-licensing, and performing financial analyses for preclinical drug assets. Will gained research experience at the University of Pennsylvania from 2018 to July 2021, contributing to multiple labs with focuses on disease ecology, epigenetics, and innate immunity. Will holds both a Master's and Bachelor's degree in Cellular and Molecular Biology from the University of Pennsylvania, completed in 2021.